Fu H. Wang

South Road Of Lushun
Dalian, 116044, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Phosphocreatine mitigates pulmonary fibrosis in STZ-induced diabetic rats with bleomycin injury through TGF-β/Smad and Wnt/β-catenin pathways.

Phosphocreatine mitigates pulmonary fibrosis in STZ-induced diabetic rats with bleomycin injury through TGF-β/Smad and Wnt/β-catenin pathways.

Journal: Tissue & cell
Published: April 01, 2026

Phosphocreatine attenuates diabetes-exacerbated kidney fibrosis via TGF-β/Smad and PI3K/Akt pathways in a dual rat model.

Phosphocreatine attenuates diabetes-exacerbated kidney fibrosis via TGF-β/Smad and PI3K/Akt pathways in a dual rat model.

Journal: Tissue & cell
Published: January 16, 2026

Tuft cells contribute to the pathogenesis of human primary and experimental murine Sjögren's disease.

Tuft cells contribute to the pathogenesis of human primary and experimental murine Sjögren's disease.

Journal: Journal of dental sciences
Published: October 17, 2025

Phosphocreatine attenuates doxorubicin-induced hepatotoxicity via activation of Nrf2/HO-1 and PGC-1α pathways in mice.

Phosphocreatine attenuates doxorubicin-induced hepatotoxicity via activation of Nrf2/HO-1 and PGC-1α pathways in mice.

Journal: Tissue & cell
Published: August 27, 2025

Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways.

Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways.

Journal: Tissue & cell
Published: April 22, 2025

Phosphocreatine ameliorates hepatocellular apoptosis mediated by protecting mitochondrial damage in liver ischemia/reperfusion injury through inhibiting TLR4 and Agonizing Akt Pathway.

Phosphocreatine ameliorates hepatocellular apoptosis mediated by protecting mitochondrial damage in liver ischemia/reperfusion injury through inhibiting TLR4 and Agonizing Akt Pathway.

Journal: Tissue & cell
Published: September 16, 2024

The neuroprotective effects of phosphocreatine on amyloid beta 25-35-induced differentiated neuronal cell death through inhibition of AKT/GSK-3β /Tau/APP/CDK5 pathways in vivo and vitro.

The neuroprotective effects of phosphocreatine on amyloid beta 25-35-induced differentiated neuronal cell death through inhibition of AKT/GSK-3β /Tau/APP/CDK5 pathways in vivo and vitro.

Journal: Free radical biology & medicine
Published: January 01, 2022

Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells.

Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells.

Journal: iScience
Published: December 23, 2020

The neuroprotective effects of phosphocreatine on Amyloid Beta 25-35-induced differentiated neuronal cell death through inhibition of AKT /GSK-3β /Tau/APP /CDK5 pathways in vivo and vitro.

The neuroprotective effects of phosphocreatine on Amyloid Beta 25-35-induced differentiated neuronal cell death through inhibition of AKT /GSK-3β /Tau/APP /CDK5 pathways in vivo and vitro.

Journal: Free radical biology & medicine
Published: October 02, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026